Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple SclerosisTim Spelman, Jan Lycke, Melinda Magyari et al.|JAMA Neurology|2021Cited by 237
Treatment decisions in multiple sclerosis — insights from real-world observational studiesMaría Trojano, Helmut Butzkueven, Mar Tintoré et al.|Nature Reviews Neurology|2017Cited by 191
Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapyBenjamin W. Teh, Monica A. Slavin, Simon J. Harrison et al.|British Journal of Haematology|2015Cited by 127
High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort StudyRachel Sacks‐Davis, Margaret Hellard, Campbell Aitken et al.|PLoS ONE|2013Cited by 69
Early treatment delays long-term disability accrual in RRMS: Results from the BMSD networkPietro Iaffaldano, María Trojano, Giuseppe Lucisano et al.|Multiple Sclerosis Journal|2021Cited by 64